Soluble fibrillar oligomer levels are elevated in Alzheimer's disease brain and correlate with cognitive dysfunction

“Mini-mental state”

Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282

Neuropathological stageing of Alzheimer-related changes.

Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123

Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397

The Association Between Quantitative Measures of Dementia and of Senile Change in the Cerebral Grey Matter of Elderly Subjects

Blessed, G., Tomlinson, B. E., & Roth, M. (1968) · British Journal of Psychiatry · doi:10.1192/bjp.114.512.797 · Cited by 4,117

Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis

Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., & Glabe, C. G. (2003) · Science · doi:10.1126/science.1079469 · Cited by 4,064

Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory

Shankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., et al. (2008) · Nature Medicine · doi:10.1038/nm1782 · Cited by 3,685

Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins

Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506

Phases of Aβ-deposition in the human brain and its relevance for the development of AD

Thal, D. R., Rüb, U., Orantes, M., & Braak, H. (2002) · Neurology · doi:10.1212/wnl.58.12.1791 · Cited by 3,490

Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective

Tanzi, R. E., & Bertram, L. (2005) · Cell · doi:10.1016/j.cell.2005.02.008 · Cited by 1,849

Structural polymorphism and cytotoxicity of brain‐derived β‐amyloid extracts

Adem, K. A., & Lee, S.-M. (2023) · Protein Science · doi:10.1002/pro.4639 · Cited by 14

Is interaction of amyloid β-peptides with metals involved in cognitive activity?

Tamano, H., & Takeda, A. (2015) · Metallomics · doi:10.1039/c5mt00076a · Cited by 19

The Luminescent Oligothiophene p-FTAA Converts Toxic Aβ1–42 Species into Nontoxic Amyloid Fibers with Altered Properties

Civitelli, L., Sandin, L., Nelson, E., Khattak, S. I., Brorsson, A., & Kågedal, K. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.696229 · Cited by 19

A novel DSC approach for evaluating protectant drugs efficacy against dementia

Abarova, S., Koynova, R. D., Tancheva, L. P., & Tenchov, B. G. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.07.033 · Cited by 19

Therapeutic Interventions Targeting Beta Amyloid Pathogenesis in an Aging Dog Model

Martin, S. B., Dowling, A. L. S., & Head, E. (2011) · Current Neuropharmacology · doi:10.2174/157015911798376217 · Cited by 19

Conformational Diseases: Structural Studies of Aggregation of Polyglutamine Proteins

Papaleo, E., & Invernizzi, G. (2010) · Current Computer - Aided Drug Design · doi:10.2174/157340911793743574 · Cited by 18

Low-temperature exothermic transitions in brain proteome of mice, effect of scopolamine

Tenchov, B. G., Abarova, S., Koynova, R. D., Traikov, L. L., & Tancheva, L. P. (2017) · Thermochimica Acta · doi:10.1016/j.tca.2017.01.012 · Cited by 18

Binding between Prion Protein and Aβ Oligomers Contributes to the Pathogenesis of Alzheimer’s Disease

Kong, C., Xie, H., Gao, Z., Shao, M., Li, H., Shi, R., Cai, L., Gao, S., Sun, T., & Li, C. (2019) · Virologica Sinica · doi:10.1007/s12250-019-00124-1 · Cited by 18

NMR metabolomic investigation of astrocytes interacted with Aβ42 or its complexes with either copper(II) or zinc(II)

Rocchi, A., Valensin, D., Aldinucci, C., Giani, G., Barbucci, R., Gaggelli, E., Kozłowski, H., & Valensin, G. (2012) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2012.08.021 · Cited by 18

Rapid Improvement of Canine Cognitive Dysfunction with Immunotherapy designed for Alzheimer's Disease

Bosch, M. N., Gimeno‐Bayón, J., Rodríguez, M. J., Pugliese, M., & Mahy, N. (2013) · Current Alzheimer Research · doi:10.2174/15672050113109990129 · Cited by 17

Conformational evolution of polymorphic amyloid assemblies

Chen, L., Hsieh, M.-C., Li, N. X., & Lynn, D. G. (2018) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2018.04.004 · Cited by 15

Oxidative Stress Boosts the Uptake of Cerium Oxide Nanoparticles by Changing Brain Endothelium Microvilli Pattern

Magro, R. D., Vitali, A., Fagioli, S., Casu, A., Falqui, A., Formicola, B., Taiarol, L., Cassina, V., Marrano, C. A., Mantegazza, F., et al. (2021) · Antioxidants · doi:10.3390/antiox10020266 · Cited by 17

Polymorphic SERPINA3 prolongs oligomeric state of amyloid beta

Akbor, M. M., Kurosawa, N., Nakayama, H., Nakatani, A., Tomobe, K., Chiba, Y., Ueno, M., Tanaka, M., Nomura, Y., & Isobe, M. (2021) · PLoS ONE · doi:10.1371/journal.pone.0248027 · Cited by 17

Experimental approaches for altering the expression of Abeta‐degrading enzymes

Loeffler, D. A. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15762 · Cited by 18

A Network Explanation of Alzheimer's Regional VulnerabilityPreprint

Small, S. A., & Swanson, L. W. (2018) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2018.83.036889 · Cited by 17

Production of Monoclonal Antibodies to Pathologic β-sheet Oligomeric Conformers in Neurodegenerative Diseases

Goñi, F., Martá-Ariza, M., Peyser, D. K., Herline, K., & Wısnıewskı, T. (2017) · Scientific Reports · doi:10.1038/s41598-017-10393-z · Cited by 16

Formation of immunoglobulin light chain amyloid oligomers in primary cutaneous nodular amyloidosis

Clos, A. L., Lasagna‐Reeves, C. A., Castillo‐Carranza, D. L., Sengupta, U., Jackson, G. R., Kelly, B. C., Beachkofsky, T. M., & Kayed, R. (2011) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2011.10508.x · Cited by 16

Pathophysiological amyloid concentrations induce sustained upregulation of readthrough acetylcholinesterase mediating anti-apoptotic effects

Li, G., Klein, J., & Zimmermann, M. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.02.040 · Cited by 16

Shedding light on aberrant interactions – a review of modern tools for studying protein aggregates

Kundel, F., Tosatto, L., Whiten, D. R., Wirthensohn, D. C., Horrocks, M. H., & Klenerman, D. (2018) · FEBS Journal · doi:10.1111/febs.14409 · Cited by 16

The role of α-sheet structure in amyloidogenesis: characterization and implications

Prosswimmer, T., & Daggett, V. (2022) · Open Biology · doi:10.1098/rsob.220261 · Cited by 16

The Anti-Prion Antibody 15B3 Detects Toxic Amyloid-β Oligomers

Stravalaci, M., Tapella, L., Beeg, M., Rossi, A., Joshi, P., Pizzi, E., Mazzanti, M., Balducci, C., Forloni, G., Biasini, E., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150882 · Cited by 15

Protein Microgels from Amyloid Fibril Networks

Roode, L. W. Y., Shimanovich, U., Wu, S., Perrett, S., & Knowles, T. P. J. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-9791-2_7 · Cited by 16

A calcium-sensitive antibody isolates soluble amyloid-β aggregates and fibrils from Alzheimer’s disease brain

Stern, A. M., Liu, L., Jin, S., Liu, W., Meunier, A. L., Ericsson, M., Miller, M. B., Batson, M., Sun, T., Kathuria, S. V., et al. (2022) · Brain · doi:10.1093/brain/awac023 · Cited by 18

Intrathecal amyloid‐beta oligomer administration increases tau phosphorylation in the medial temporal lobe in the African green monkey: A nonhuman primate model of Alzheimer's disease

Wakeman, D. R., Weed, M. R., Perez, S. E., Cline, E. N., Viola, K. L., Wilcox, K. C., Moddrelle, D. S., Nisbett, E. Z., Kurian, A., Bell, A., et al. (2022) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12800 · Cited by 18

PPARα Activation Attenuates Amyloid-β-Dependent Neurodegeneration by Modulating Endo G and AIF Translocation

Cheng, Y.-H., Lai, S., Chen, P.-Y., Chang, J., & Chang, N. W. (2014) · Neurotoxicity Research · doi:10.1007/s12640-014-9485-9 · Cited by 15

Discrete Pools of Oligomeric Amyloid-β Track with Spatial Learning Deficits in a Mouse Model of Alzheimer Amyloidosis

Chiang, A. C. A., Fowler, S., Reddy, R., Pletniková, O., Troncoso, J. C., Sherman, M. A., Lesné, S., & Jankowsky, J. L. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2017.11.011 · Cited by 17

Data-driven modeling of mitochondrial dysfunction in Alzheimer's disease

Toglia, P. T., Demuro, A., Mak, D. D., & Ullah, G. (2018) · Cell Calcium · doi:10.1016/j.ceca.2018.09.003 · Cited by 15

Amyloid fibril inhibition, acceleration, or fragmentation; Are nano-based approaches advance in the right direction?

Hajipour, M. J., Mohammad‐Beigi, H., Nabipour, I., Mahmoudi, N., Azhdarzadeh, M., Derakhshankhah, H., Dawud, D. E., Mohammadinejad, R., & Otzen, D. E. (2020) · Nano Today · doi:10.1016/j.nantod.2020.100983 · Cited by 14

Improved Neuroprotection Provided by Drug Combination in Neurons Exposed to Cell-Derived Soluble Amyloid-β Peptide

Colin, J., Allouche, A., Chauveau, F., Corbier, C., Gregory, L., Lanhers, M., Claudepierre, T., Yen, F. T., Oster, T., & Malaplate, C. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-151110 · Cited by 14

The N-terminal region of myelin basic protein reduces fibrillar amyloid-β deposition in Tg-5xFAD mice

Ou-Yang, M.-H., Xu, F., Liao, M.-C., Davis, J., Robinson, J. K., & Nostrand, W. E. V. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.10.006 · Cited by 14

The effect of α-tocopherol, α- and γ-tocotrienols on amyloid-β aggregation and disaggregation in vitro

Ibrahim, N. F., Hamezah, H. S., Yanagisawa, D., Tsuji, M., Kiuchi, Y., Ono, K., & Tooyama, I. (2021) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2021.101131 · Cited by 13

Virus-Like Cytosolic and Cell-Free Oxidatively Damaged Nucleic Acids Likely Drive Inflammation, Synapse Degeneration, and Neuron Death in Alzheimer’s Disease

Sanders, O. D. (2022) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-220047 · Cited by 13

Alterations in the Expression of the Genes Responsible for the Synthesis of Heparan Sulfate in Brains With Alzheimer Disease

Pérez-López, N., Martín, C., García, B., Solís-Hernández, M. P., Rodrı́guez, D., Alcalde, I., Merayo, J., Fernández‐Vega, I., & Quirós, L. M. (2021) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlab028 · Cited by 14

C9ORF72-derived poly-GA DPRs undergo endocytic uptake in iAstrocytes and spread to motor neurons

Marchi, P. M., Marrone, L., Brasseur, L., Coens, A., Webster, C. P., Bousset, L., Destro, M., Smith, E. F., Walther, C. G., Alfred, V., et al. (2022) · Life Science Alliance · doi:10.26508/lsa.202101276 · Cited by 17

Multiscale causal network models of Alzheimer’s disease identify VGF as a key regulator of diseasePreprint

Beckmann, N., Lin, W.-J., Wang, M.-H., Cohain, A., Wang, P., Ma, W., Wang, Y.-C., Jiang, C., Audrain, M., Comella, P., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/458430 · Cited by 12

Neuronal and Glial α7 Nicotinic Acetylcholine Receptors: Role in Alzheimer’s Disease Pathophysiology

Rennie, K. (2025) · Life · doi:10.3390/life15071032 · Cited by 11

Designed De Novo α-Sheet Peptides Destabilize Bacterial Biofilms and Increase the Susceptibility of E. coli and S. aureus to Antibiotics

Prosswimmer, T., Nick, S. E., Bryers, J. D., & Daggett, V. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137024 · Cited by 11

BODIPY in Alzheimer's disease diagnostics: A review

Abramchuk, D., Voskresenskaya, A. S., Kuzmichev, I., Erofeev, A. S., Gorelkin, P. V., Abakumov, M. A., Beloglazkina, E. K., & Krasnovskaya, O. O. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116682 · Cited by 11

Correlation of Polydispersed Prion Protein and Characteristic Pathology in the Thalamus in Variant Creutzfeldt‐Jakob Disease: Implication of Small Oligomeric Species

Choi, Y. P., Gröner, A., Ironside, J. W., & Head, M. W. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2010.00446.x · Cited by 11

Quantifying the dose-dependent impact of intracellular amyloid beta in a mathematical model of calcium regulation in xenopus oocyte

Minicucci, J., Alfond, M., Demuro, A., Gerberry, D. J., & Latulippe, J. (2021) · PLoS ONE · doi:10.1371/journal.pone.0246116 · Cited by 10

Immunomodulation and AD – Down But Not Out

Knight, E. M., & Gandy, S. (2014) · Journal of Clinical Immunology · doi:10.1007/s10875-014-0039-y · Cited by 12

The role ofECE1variants in cognitive ability in old age and Alzheimer's disease risk

Hamilton, G., Harris, S. E., Davies, G., Liewald, D. C. M., Tenesa, A., Payton, A., Horan, M. A., Ollier, W., Pendleton, N., Starr, J. M., et al. (2012) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32073 · Cited by 11

In vitro, cellular and in vivo studies of amyloid oligomers structure and toxicity: Challenges and advances

Ivanova, M. I., Rosa, C. L., & Ramamoorthy, A. (2026) · Protein Science · doi:10.1002/pro.70525 · Cited by 10

Neuronal Differentiation of Human Mesenchymal Stromal Cells Increases their Resistance to Aβ42 Aggregate Toxicity

Cecchi, C., Evangelisti, E., Cascella, R., Zampagni, M., Benvenuti, S., Luciani, P., Deledda, C., Cellai, I., Wright, D., Saccardi, R., et al. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110590 · Cited by 10

Formation of lamellar micelle-like oligomers and membrane disruption revealed by the study of short peptide hIAPP 18–27

Wei, Y., Lu, J., Lu, T., Meng, F., Xu, J., Wang, L., Li, Y., Wang, L., & Li, F. (2016) · Physical Chemistry Chemical Physics · doi:10.1039/c6cp04431j · Cited by 10

Depletion of amyloid‐β peptides from solution by sequestration within fibril‐seeded hydrogels

Yau, W., & Tycko, R. (2018) · Protein Science · doi:10.1002/pro.3387 · Cited by 11

Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps

Sajadi, A., Provost, C., Pham, B., & Brouillette, J. (2016) · Journal of Visualized Experiments · doi:10.3791/54215 · Cited by 10

Inhibition of insulin-degrading enzyme in human neurons promotes amyloid-β deposition

Rowland, H. A., Moxon, S. R., Corbett, N. J., Hanson, K., Fisher, K., Kellett, K. A. B., & Hooper, N. M. (2023) · Neuronal Signaling · doi:10.1042/ns20230016 · Cited by 15

The Domestic Dog as a Model for Human Brain Aging and Alzheimer’s Disease

Schütt, T., Pedersen, J. T., & Berendt, M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811353-0.00015-4 · Cited by 9

Production of Therapeutic Single-Chain Variable Fragments (ScFv) in Pichia pastoris

Montoliu‐Gaya, L., & Villegas, S. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1450-1_8 · Cited by 9

Wild‐type, Flemish, and Dutch amyloid‐β exhibit different cytotoxicities depending on Aβ40 to Aβ42 interaction time and concentration ratio

Shahnawaz, M., Sharoar, M. G., Shin, S. Y., & Park, I. (2013) · Journal of Peptide Science · doi:10.1002/psc.2531 · Cited by 9

Conformation-Dependent Oligomers in Cerebrospinal Fluid of Presymptomatic Familial Alzheimer’s Disease Mutation Carriers

Ringman, J. M., Tomic, J. L., Coppola, G., Elashoff, D. A., Gylys, K. H., & Glabe, C. G. (2012) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000345771 · Cited by 9

The Aged Dog as a Natural Model of Alzheimer’s Disease Progression

Araujo, J. A., Baulk, J., & de Rivera, C. (2017) · Springer eBooks · doi:10.1007/978-3-319-53219-6_4 · Cited by 9

The Amyloid Phenomenon and Its Significance

Dobson, C. M. (2013) · Wiley eBooks · doi:10.1002/9783527654185.ch1 · Cited by 9

Intracellular Injection of Brain Extracts from Alzheimer’s Disease Patients Triggers Unregulated Ca2+ Release from Intracellular Stores That Hinders Cellular Bioenergetics

Pensalfini, A., Umar, A. R., Glabe, C. G., Parker, I., Ullah, G., & Demuro, A. (2022) · Cells · doi:10.3390/cells11223630 · Cited by 8

Characterizing the Oligomers Distribution along the Aggregation Pathway of Amyloid Aβ1‐40 by NMR

Pagano, K., Rosa, L. D., Tomaselli, S., Molinari, H., D’Andrea, L. D., & Ragona, L. (2024) · Chemistry - A European Journal · doi:10.1002/chem.202400594 · Cited by 10

Preparation and Characterization of Zn(II)-Stabilized Aβ42 Oligomers

Díaz, A. G., Cataldi, R., Mannini, B., & Vendruscolo, M. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00084 · Cited by 10

Rethinking early Alzheimer’s disease: An impaired internal model updating disorder?

Antonioni, A. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106790 · Cited by 8

New insights on Alzheimer's disease

El-Desouki, R. A. K. M. (2014) · Journal of Microscopy and Ultrastructure · doi:10.1016/j.jmau.2014.01.002 · Cited by 7

Efficacy of Ginkgo biloba as an adjunct to donepezil in amyloid PET-positive Alzheimer’s patients

Yang, Y., Koo, M., & Kwak, Y. T. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1563056 · Cited by 8

Automatic Analysis of Dot Blot Images

Caridade, C. M. R., Marcal, A. R. S., Albuquerque, P., Mendes, M. V., & Tavares, F. (2015) · Intelligent Automation & Soft Computing · doi:10.1080/10798587.2015.1012849 · Cited by 6

Dual roles of tau R peptides on Cu(II)/(I)-mediated reactive oxygen species formation

Golec, C., Mortensen, S., Anwar, S., & Martić, S. (2021) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-021-01902-7 · Cited by 6

Interactions of Polyphenolic Gallotannins with Amyloidogenic Polypeptides Associated with Alzheimer’s Disease: From Molecular Insights to Physiological Significance

Khalifa, J., Bourgault, S., & Gaudreault, R. (2023) · Current Alzheimer Research · doi:10.2174/0115672050277001231213073043 · Cited by 6

Specific and efficient anti-Aβ42 antibodies induced by sixteen tandem repeats of Aβ9

Cui, L., Huang, X., Wang, J., & Zhang, Y. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.06.004 · Cited by 6

Positron Emission Tomography in Alzheimer Disease

Schmidt, M. E., Matthews, D. C., Andrews, R. D., & Mosconi, L. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-386945-6.00005-6 · Cited by 7

The relationship between postoperative delirium and plasma amyloid beta oligomer

Yang, Y., Jung, K. J., & Kwak, Y. T. (2025) · Scientific Reports · doi:10.1038/s41598-025-97577-0 · Cited by 5

α-Enolase reduces cerebrovascular Aβ deposits by protecting Aβ amyloid formation

Inoue, Y., Tasaki, M., Masuda, T., Misumi, Y., Nomura, T., Ando, Y., & Ueda, M. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04493-x · Cited by 7

Follow-up Comparisons of Two Plasma Biomarkers of Alzheimer’s Disease, Neurofilament Light Chain, and Oligomeric Aβ: A Pilot Study

Shim, Y. (2023) · Current Alzheimer Research · doi:10.2174/0115672050284054240119101834 · Cited by 5

The Unexposed Secrets of Prion Protein Oligomers

Wang, G., Wang, M., & Li, C. (2015) · Journal of Molecular Neuroscience · doi:10.1007/s12031-015-0546-1 · Cited by 5

Early Detection of Amyloid β Pathology in Alzheimer’s Disease by Molecular MRI

Dong, C. M., Guo, A. S., To, A., Chan, K. W. Y., Chow, A. S. F., Bian, L., Leong, A. T. L., & Wu, E. X. (2020) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc44109.2020.9176013 · Cited by 5

The Innate Immune System in Alzheimer's Disease

Beckert, H., & Halle, A. (2013) · Else Kröner-Fresenius Symposia · doi:10.1159/000346509 · Cited by 4

Sleep deprivation aggravated amyloid β oligomers-induced damage to the cerebellum of rats: Evidence from magnetic resonance imaging

Guo, W., Mao, X., Han, D., Wang, H., Zhang, W., Zhang, G., Zhang, N., Nie, B., Li, H., Song, Y., et al. (2023) · Aging Brain · doi:10.1016/j.nbas.2023.100091 · Cited by 4

Defining the Neuropathological Aggresome across in Silico, in Vitro, and ex Vivo Experiments

Gomes, G.-N. W., & Levine, Z. A. (2021) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.0c09193 · Cited by 4

Phytochemical analysis, antioxidant and anti-inflammatory activity of leaves and bark of Ceropegia rollae Hemadri

Nayak, S. S., Mirgane, N. A., Pathade, K. B., Shivankar, V. S., & Wadhawa, G. C. (2021) · Plant Science Today · doi:10.14719/pst.2021.8.3.906 · Cited by 4

The Role of Aβ in Alzheimer's Disease

Ryan, T. M., Roberts, B. R., Streltsov, V. A., Nuttall, S. D., & Masters, C. L. (2013) · doi:10.1002/9783527654185.ch13 · Cited by 4

Structural Model for Self-Limiting β-strand Arrangement Within an Alzheimer’s Amyloid-β OligomerPreprint

Gao, Y., Prasad, R., Randolph, P. S., Watzlawik, J. O., Robang, A. S., Guo, C., Stagg, S. M., Zhou, H., Rosenberry, T. L., & Paravastu, A. K. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.12.06.519347 · Cited by 4

Slow Misfolding of a Molten Globule form of a Mutant Prion Protein Variant into a β-rich Dimer

Pal, S., & Udgaonkar, J. B. (2024) · Journal of Molecular Biology · doi:10.1016/j.jmb.2024.168736 · Cited by 3

Direct ortho‐Selective Amination of Naphthols with Nitroarenes through Transfer‐Hydrogenation

Ma, R., Zhang, R. Q., Xia, H., Wang, L., & Ma, Y. (2024) · European Journal of Organic Chemistry · doi:10.1002/ejoc.202400089 · Cited by 3

Reporters of Amyloid Structural Polymorphism

LeVine, H., Nilsson, K. P. R., Nilsson, R., & Hammarström, P. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-394431-3.00007-9 · Cited by 3

Structural Dynamics of Amyloid-β Aggregation in Alzheimer’s Disease: Computational and Experimental Approaches

Cheng, C. W. H., Chung, M. H. H., & Ng, J. C.-F. (2016) · doi:10.22186/jyi.31.6.44-50 · Cited by 3

Candidate biomarkers and CSF profiles for alzheimer’s disease and CADASIL

Bowirrat, A., Bisharat, B., William, N., Muhamad, O., & Yassin, M. (2015) · Journal of Alzheimer’s Disease & Parkinsonism · Cited by 2

Electrochemical (Bio) Sensing of Amyloid Beta Peptide (Aβ) using Metallic Nanoparticles

Karastogiann, S. (2020) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2020.32.005274 · Cited by 1

Lack of association between cortical amyloid deposition and glucose metabolism in early stage Alzheimer´s disease patients

Ehrlich, D., Dunzinger, A., Malsiner‐Walli, G., Grün, B., Topakian, R., Hodolič, M., Kainz, E., & Pichler, R. (2021) · Radiology and Oncology · doi:10.2478/raon-2021-0051 · Cited by 3

Treatment of Alzheimer’s disease by promoting the aggregation of small β-amyloid peptides

JiWei, M. A. I., ZHANG, J., & Dou, F. (2022) · Scientia Sinica Vitae · doi:10.1360/ssv-2022-0143 · Cited by 2

Distribution of Transmissible Amyloid Proteins in the Liver with Apolipoprotein A-II Amyloidosis

Liu, Y., Sawashita, J., Wang, Y., Li, L., Miyahara, H., Ding, X., Yang, M., & Higuchi, K. (2016) · SOAR (Shinshu University) · Cited by 2

Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps

Sajadi, A., Provost, C., Pham, B., & Brouillette, J. (2016) · Journal of Visualized Experiments · doi:10.3791/54215-v · Cited by 2

Performance of SOBA-AD blood test in discriminating Alzheimer’s disease patients from cognitively unimpaired controls in two independent cohorts

Chen, A., Shea, D. W., & Daggett, V. (2024) · Scientific Reports · doi:10.1038/s41598-024-57107-w · Cited by 1

Plasma amyloid‐β oligomerization tendency as a potential predictor for conversion from mild cognitive impairment to Alzheimer's dementia: Findings from the GMCII cohort

Xie, Y., Meng, X. W., Li, T., Zhang, H., Zheng, Y., Kim, S.-Y., Zhang, C., Yu, X., & Wang, H. (2025) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.70064 · Cited by 1

A prospective pilot study on plasma amyloid beta oligomers and postoperative delirium

Yang, Y., Jung, K. J., & Kwak, Y. T. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1673496 · Cited by 1

PROTEIMERs as catalytic inhibitors of APP mRNA translation: Toward a new therapeutic for Alzheimer's disease

von Salzen, D., Senn, K. A., Cho, H. K., Cahill, C. M., Rogers, J. T., & Cho, H. D. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251393907 · Cited by 1

Conformation-Dependent Antibodies as Tools for Characterization of Amyloid Protein Aggregates

Wu, J., & Breydo, L. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-394431-3.00008-0 · Cited by 1

Biological Targeting and Activity of Pre-fibrillar Aβ Assemblies

Wilcox, K. C., Pitt, J. E., Sebollela, A. S., Martirosova, H., Lacor, P. N., & Klein, W. L. (2011) · Springer eBooks · doi:10.1007/978-94-007-2774-8_4 · Cited by 1

Amyloid Hypothesis: Molecular and Cellular Aspects of Toxicity

Kayed, R., & Lasagna‐Reeves, C. A. (2013) · Modecular medicine and medicinal · doi:10.1142/9781848167551_0001 · Cited by 2

The Role of Aβ in the Development of Alzheimer’s Disease and its Mechanisms

Jin, Y. (2020) · E3S Web of Conferences · doi:10.1051/e3sconf/202021803041 · Cited by 1

Competitive Superiority by Bi-flavonoids to Mono-flavonoids in Inhibiting Amyloid-β Toxicity and Fibrillogenesis through Accumulating Nontoxic Oligomer-like Structures

Jayalal, L. P. M. (2013) · Journal of the Chosun Natural Science · doi:10.13160/ricns.2013.6.2.87 · Cited by 1

Blutbasierte Mikrozirkulationsmarker bei der Alzheimer-Demenz

Knauer, K. (2010) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.12369

Pathological and cognitive alterations in mouse models of traumatic brain injury and hypoperfusion

Spain, A. (2011) · ERA

ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR REGULATION IN EXPERIMENTAL NEURODEGENERATIVE DISEASE

Charriez, C. M. (2010) · UKnowledge (University of Kentucky)

A Correlative Study on Amyloid-β Variants Exhibit Different Cytotoxicities Depending on Ratio of β40 to Aβ42 and Their Interaction Time and Implication of Aβ40 as a Primary Determinant for the Variable Cytotoxicities in Wild-type, Flemish and Dutch

Jayalal, L. P. M. (2013) · Journal of the Chosun Natural Science · doi:10.13160/ricns.2013.6.1.021

A fibril-specific, conformation-dependent antibody recognizes a subset of Aβ plaques in Alzheimer disease, Down syndrome and Tg2576 transgenic mouse brain

Sarsoza, F. M., Saing, T., Kayed, R., Dahlin, R., Dick, M. B., Broadwater-Hollifield, C., Mobley, S., Lott, I. T., Doran, E. W., Gillen, D. L., et al. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0530-3 · Cited by 44

Amyloid-β Oligomers Relate to Cognitive Decline in Alzheimer's Disease

Jongbloed, W., Bruggink, K. A., Kester, M. I., Visser, P.-J., Scheltens, P., Blankenstein, M. A., Verbeek, M. M., Teunissen, C. E., & Veerhuis, R. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-142136 · Cited by 68

Oligomeric Aβ in Alzheimer's Disease: Relationship to Plaque and Tangle Pathology, APOE Genotype and Cerebral Amyloid Angiopathy

Helmond, Z. V., Miners, J. S., Kehoe, P. G., & Love, S. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2009.00321.x · Cited by 44

Discrete Pools of Oligomeric Amyloid-β Track with Spatial Learning Deficits in a Mouse Model of Alzheimer Amyloidosis

Chiang, A. C. A., Fowler, S., Reddy, R., Pletniková, O., Troncoso, J. C., Sherman, M. A., Lesné, S., & Jankowsky, J. L. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2017.11.011 · Cited by 17

P2‐256: Histological localization of amyloid‐β oligomers in the human brain during the course of Alzheimer's disease

Panchal, M., Lacor, P. N., Klein, W. L., & Duyckaerts, C. J. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.05.1137